Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer
β Scribed by Maryam Parviz; Jay Brian Cassel; Brian J. Kaplan; Stephen E. Karp; James P. Neifeld; Lynne T. Penberthy; Harry D. Bear
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 119 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Backgrounds and Objectives: We present the interim findings of our in-house protocol treating the tumor bed alone after lumpectomy with low-dose-rate (LDR) interstitial brachytherapy in selected patients with early-stage breast cancer treated with breast conserving therapy (BCT). Methods: From
## Abstract ## BACKGROUND The purpose of the current analysis was to evaluate the impact of local recurrence (LR) on the development of distant metastases (DM), overall survival (OS), and cause specific survival (CSS) in patients with earlyβstage breast carcinoma who underwent conservative surgery
## Abstract ## BACKGROUND. Results from numerous trials have indicated that breastβconserving therapy (BCT) produces outcomes equivalent to those produced by mastectomy in terms of both locoregional control and survival. However, conservative treatment has resulted in the dilemma of how best to ad
W e read the interesting article by Jagsi et al on the increased rates of coronary artery disease in patients treated with radiation therapy for early-stage breast cancer. 1 In their study, those authors concluded that the findings support further assessment of clinical outcomes when newer technique